Transmedics Group Stock

Transmedics Group Assets per Share

The Total Assets per Share of Transmedics Group (TMDX) as of Aug 14, 2026 is 31.27 USD. In the previous year, Total Assets per Share was 23.53 USD — a change of 32.87% (higher).

Assets per Share

31.27USD

YoY

32.87%

Last updated:

Total Assets per Share of Transmedics Group is 2026 31.27 USD. Total Assets per Share of Transmedics Group was 2025 23.53 USD. It decreases by 32.87% higher compared to the previous year.
Access this data via the Eulerpool API

Transmedics Group Stock analysis

What does Transmedics Group do? Transmedics Group Inc is a company dedicated to the development and manufacturing of medical devices for organ transplantation. The company was founded in 1998 and is headquartered in Andover, Massachusetts, USA. Transmedics' business model is based on offering a unique and innovative technology for organ preservation during transport from donor to recipient. The patented Organ Care System (OCS) platform includes a range of state-of-the-art medical devices specifically designed for organ transport. Transmedics' Organ Care System includes three main devices: OCS Heart, OCS Lung, and OCS Liver. Each device is tailored for organ preparation and transport, providing individualized support based on the specific requirements of each organ and different transfer protocols. The OCS technology uses hypothermic (cold) perfusion to preserve the organ during transport. By continuously monitoring and supporting the organ's physiological functions, the OCS system can improve the survival rate of donor organs while reducing the time spent outside the body. Transmedics also offers comprehensive services, including the availability of OCS devices and qualified personnel to provide support throughout the transplantation process. Transmedics' customers include leading transplant centers and hospitals worldwide. The company works closely with these customers to ensure that its OCS devices meet the specific requirements of each transplantation program and help them achieve more successful transplantations. Transmedics' history is marked by a passion for improving transplantation medicine and saving lives through the provision of advanced technologies and solutions. The company has made significant progress in recent years and has experienced strong growth in all areas. Transmedics has also received a number of awards and recognition for its commitment to improving transplantation medicine. For example, in 2020, the company received the Red Herring Top 100 Global Award and was recognized for the seventh consecutive year as one of the fastest-growing companies by Deloitte. Overall, Transmedics is a leading provider of innovative medical devices for transplantation medicine. Through its organic technology and comprehensive service, the company supports transplant centers and hospitals worldwide in performing more successful transplantations and saving patients' lives. Transmedics Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transmedics Group stock

Total Assets per Share of Transmedics Group is 31.27 USD in 2026.

Total Assets per Share of Transmedics Group changed from 23.53 USD to 31.27 USD, representing a 32.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Transmedics Group since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

Other — Transmedics Group

All Key Metrics — Transmedics Group